Cite
Crohn's disease patients treated with adalimumab benefit from co-treatment with immunomodulators: Table 1
MLA
Martijn G.H. van Oijen, et al. “Crohn’s Disease Patients Treated with Adalimumab Benefit from Co-Treatment with Immunomodulators: Table 1.” Gut, vol. 61, Mar. 2011, p. 324.2-325. EBSCOhost, https://doi.org/10.1136/gut.2011.239889.
APA
Martijn G.H. van Oijen, Bas Oldenburg, Marije J. Ammerlaan, Mirthe E. van der Valk, & Peter D. Siersema. (2011). Crohn’s disease patients treated with adalimumab benefit from co-treatment with immunomodulators: Table 1. Gut, 61, 324.2-325. https://doi.org/10.1136/gut.2011.239889
Chicago
Martijn G.H. van Oijen, Bas Oldenburg, Marije J. Ammerlaan, Mirthe E. van der Valk, and Peter D. Siersema. 2011. “Crohn’s Disease Patients Treated with Adalimumab Benefit from Co-Treatment with Immunomodulators: Table 1.” Gut 61 (March): 324.2-325. doi:10.1136/gut.2011.239889.